Homepage | Michael Asger Andersen
Clinical Pharmacologist & Researcher
Working at the intersection of personalized medicine and pharmacology
Recent projects
VISION-TDM A study optimizing venetoclax and ibrutinib dosing through therapeutic drug monitoring, combining retrospective analyses with prospective clinical data.
SAMSON2 A study to examine statin intolerance using a N-of-1 trial design
CYP2C19 Pharmacogenetic Testing A study evaluating the clinical utility of CYP2C19 genotyping in clopidogrel therapy through both retrospective analysis and prospective patient data.
Technical Expertise
- Statistical methods: Survival analysis, generalized additive models
- Programming: R (data.table, heaven, mgcv)
- Data sources: Danish health registers, clinical databases